Double Filtration Plasmapheresis for Thyroid Storm With Encephalopathy: A Case Report
Journal of Clinical Apheresis · 2025
DOI: 10.1002/jca.70063 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Apheresis, 2025. Verfasst von Qisheng Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Plasmapheresis, Thyroid Crisis, Graves Disease, Brain Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Renji Hospital, National Natural Science Foundation of China, Shanghai Sailing Program.
Abstract (Originalsprache)
Thyroid storm is a life‐threatening endocrine emergency with a mortality rate of up to 17%. Standard treatment includes antithyroid drugs (ATD), β‐blockers, and glucocorticoids. However, some patients may require blood purification therapies, such as plasmapheresis, due to the ineffectiveness of standard treatments or contraindications like agranulocytosis. We report the case of a 38‐year‐old female with Graves' disease who was admitted for thyroid storm (Burch–Wartofsky score of 70) combined with encephalopathy, presenting with impaired consciousness, seizures, and leukopenia (1.82 × 10 9 /L). Due to contraindications for ATD, she was treated with double filtration plasmapheresis (DFPP). After three sessions, her anti‐thyrotropin receptor antibodies (TRAb > 40–29.8 IU/L) and thyroid hormones (FT4 88.7–19.7 pmol/L) significantly decreased, and her consciousness improved. She was later transitioned successfully to oral ATD upon discharge. Plasmapheresis can rapidly remove thyroid hormones and autoantibodies, particularly useful in cases where ATD is ineffective or contraindicated. While international reports predominantly describe plasma exchange (PE), this case is the first to suggest the efficacy and safety of DFPP in treating thyroid storm with thyrotoxic encephalopathy. DFPP selectively removes large‐molecule antibodies while minimizing the use of blood products and albumin loss. For severe thyroid storm patients, early plasmapheresis may improve prognosis; however, the optimal timing, modality, and dosing require further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Qisheng Lin, Haijiao Jin
Förderung
- Renji Hospital
- National Natural Science Foundation of China
- Shanghai Sailing Program
- Shanghai Municipal Health Commission Clinical Research Special Project
- Institute of Molecular Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Nucleic Acid Chemistry and Nanomedicine, Clinical…
- Institute of Molecular Medicine, School of Medicine, Shanghai Jiao Tong University
Zitieren
APA
Lin, Q., Jin, H., Xu, Y., Xie, Y., Zhou, Y., & Lu, R. (2025). Double Filtration Plasmapheresis for Thyroid Storm With Encephalopathy: A Case Report. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70063
Vancouver
Lin Q, Jin H, Xu Y, Xie Y, Zhou Y, Lu R. Double Filtration Plasmapheresis for Thyroid Storm With Encephalopathy: A Case Report. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70063
BibTeX
@article{Lin2025,
author = {Lin, Qisheng and Jin, Haijiao and Xu, Yao and Xie, Yuanyuan and Zhou, Yijun and Lu, Renhua},
title = {Double Filtration Plasmapheresis for Thyroid Storm With Encephalopathy: A Case Report},
journal = {Journal of Clinical Apheresis},
year = {2025},
doi = {10.1002/jca.70063}
}
EUVIMED